NICE approves psoriasis drug
- Published: 07 July 2008 16:25
- Author: Steve Ford
- More by this Author
- Last Updated: 07 July 2008 16:41
- Reader Responses
NICE has approved adalimumab (Humira) for use as a treatment for chronic plaque psoriasis in adults.
It is currently the only fully human anti-TNF monoclonal antibody licensed for treating plaque psoriasis in the UK.
The drug was recommended by NICE for treating severe active ankylosing spondylitis in May, and it was approved in Scotland for psoriasis last month.
